Bausch Health Companies Inc.
Approval Represents an Important Breakthrough in One of the Largest Medical Aesthetics Markets
(*CORRECTION to the release that was posted earlier on January 18, 2024: The TR-4 Return Pad is approved for use by the U.S. Food & Drug Administration (as part of the Thermage FLX device registration) See sentence below.*)
LAVAL, QC / ACCESSWIRE / January 18, 2024 / Bausch Health Companies Inc. (NYSE/TSX:BHC) and Solta Medical, a global leader in the medical aesthetics market, today announced the approval of Thermage® FLX and the TR-4 Return Pad by China's National Medical Products Administration (NMPA). [See *Correction above: The TR-4 Return Pad is not approved for use by the U.S. Food & Drug Administration.]
"The approval of Thermage FLX, and the TR-4 return pad, marks a significant milestone for Solta Medical," Thomas J. Appio, Bausch Health Chief Executive Officer, said. "Not only is this important for growing our business, but it also represents an enormous achievement for our R&D and Regulatory Teams, who worked tirelessly with the NMPA."
Thermage is a non-invasive treatment that uses radiofrequency technology to help tighten and improve the smoothness and texture of the skin's surface to optimize a patient's appearance. Thermage is a versatile and effective treatment that can be used on all skin types and genders, on a wide range of areas on the face, body and around the eyes. Globally, more than two million Thermage treatments have been performed.
"The approval from NMPA means we are able to continue the momentum of the growth of Thermage in China," Jiny Kim, Senior Vice President, Solta Medical, said. "Building on the legacy of Thermage CPT, which has been serving Chinese institutions and consumers effectively since 2015, we look forward to delivering the Thermage FLX proven technology to the Chinese market."
Indications
• The radiofrequency energy only delivery components of the Thermage® CPT and FLX system and accessories are indicated for use in:
o Non-invasive treatment of wrinkles around the eyes, including upper and lower eyelids
o Non-invasive treatment of wrinkles
• The simultaneous application of radiofrequency energy and skin vibration by the Thermage® CPT and FLX system and accessories are indicated for use in:
o Non-invasive treatment of wrinkles around the eye
o Non-invasive treatment of wrinkles
o Temporary improvement in the appearance of cellulite
Important Safety Information
- Do not undergo Thermage treatment if you have a cardiac pacemaker, a cardioverter, a defibrillator, or any other electrical implant. Let your doctor know if you have an electrical implant or if you have any questions about whether you should undergo a Thermage® treatment.
- Solta Medical has not studied the use of the Thermage system:
- Over skin fillers (lips, cheeks, facial wrinkles and skin folds)
- In people who are pregnant and/or breast feeding, diabetic, have an auto-immune disease such as lupus, have cold sores, have genital herpes, or have epilepsy
- In people who have permanent make-up and/or tattoos
- In children
- The most commonly reported adverse effect during treatment is mild to moderate pain in the area being treated.
- The most commonly reported adverse effects after treatment include the following:
- Mild redness may occur and typically resolves within 24 hours.
- Swelling may occur and typically resolves within 5 days but can remain up to several weeks.
- The following adverse effects occur infrequently:
- The procedure may produce heating in the upper layers of the skin, causing burns and subsequent blister and scab formation. There is a possibility of scar formation.
- Skin surface irregularities may appear up to 1 or more months post-treatment.
- Numbness, tingling" or temporary paralysis may occur; typically resolves in a short period of time but may persist up to several weeks.
- Lumps or nodules may occur under the skin primarily in the neck area, and usually resolve within 1 or 2 weeks without chronic or long-term complications.
- Skin may darken, but normally resolves within several months.
Ask your doctor for more information about Thermage FLX and see www.thermage.com for additional details.
About Solta Medical
Solta Medical, a business unit of Bausch Health, is a global leader in the medical aesthetics market. Our vision at Solta is to develop and support trusted aesthetic brands that provide value to our customers and their patients. The Thermage® RF systems, Fraxel® laser, Clear + Brilliant® laser, and VASER® ultrasonic system provide exceptional results for patients and lasting growth to physicians due to our foundation of brands that have stood the test of time. More than five million procedures have been performed with Solta Medical's portfolio of products around the world. More information can be found at www.solta.com.
About Bausch Health
Bausch Health Companies Inc. (NYSE/TSX:BHC) is a global diversified pharmaceutical company whose mission is to improve people's lives with our health care products. We develop, manufacture and market a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals and eye health, through our controlling ownership interest in Bausch +Lomb. With our leading durable brands, we are delivering on our commitments as we build an innovative company dedicated to advancing global health. For more information, visit www.bauschhealth.com and connect with us on Twitter and LinkedIn.
Forward-looking Statements
This news release may contain forward-looking statements about the future performance of Bausch Health, which may generally be identified by the use of the words "anticipates," "hopes," "expects," "intends," "plans," "should," "could," "would," "may," "believes," "subject to" and variations or similar expressions, including statements about the expected results of, and market for, the Company's Thermage® treatment. These statements are based upon the current expectations and beliefs of management and are subject to certain risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. Actual results are subject to other risks and uncertainties that relate more broadly to Bausch Health's overall business, including those more fully described in Bausch Health's most recent annual report on Form 10-K and detailed from time to time in Bausch Health's other filings with the U.S. Securities and Exchange Commission and the Canadian Securities Administrators, which factors are incorporated herein by reference.
SOURCE: Bausch Health Companies Inc.
View the original press release on accesswire.com
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.
About ACCESS Newswire
Subscribe to releases from ACCESS Newswire
Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESS Newswire
Global Sports Brand U.S. Polo Assn. to Become Title Sponsor of the Palm Beaches Marathon28.8.2025 15:00:00 CEST | Press release
Marathon Returns December 13-14, 2025, Early Registration Now Open WEST PALM BEACH, FLORIDA / ACCESS Newswire / August 28, 2025 / U.S. Polo Assn., the official sports brand of the United States Polo Association (USPA), has agreed to a multi-year partnership as the new title sponsor of The Palm Beaches Marathon. The U.S. Polo Assn. Palm Beaches Marathon, a race owned and managed by Ken Kennerly's K2 Sports Ventures, will be held in Downtown West Palm Beach, Florida, on December 13-14, 2025. This renowned marathon event is recognized for its beautiful views of the waterfront and palm-tree-lined streets and welcomes runners from across the country and around the world to the warmth of Florida during the cold winter months. It is also a qualifier for the legendary Boston Marathon. "U.S. Polo Assn. is honored to be the Title Sponsor of The Palm Beaches Marathon, an iconic event that, like our brand, is deeply rooted in this vibrant community of Palm Beach County," said J. Michael Prince, Pr
Hydrosat Secures Major European Contract to Advance Large-Scale Water Productivity Mapping28.8.2025 13:30:00 CEST | Press release
The contract will leverage Hydrosat's AI-powered thermal data to help governments and institutions monitor and optimise agricultural water. LUXEMBOURG, LU / ACCESS Newswire / August 28, 2025 / Hydrosat, a company leveraging thermal satellite data and AI to address global challenges in food production, security, and natural resource management, announced today that it has been awarded a contract by the European Space Agency (ESA), under the LuxIMPULSE programme, to develop a large-scale water productivity tool for regional and national applications. Governments and agricultural stakeholders are under mounting pressure to optimise water use while balancing the competing demands of cities, industry, and the environment. Addressing this challenge requires accurate, crop-specific insights into water needs, usage patterns, soil moisture, and yield forecasts - all information that has historically been limited or unreliable. Hydrosat's solution will enable large-scale mapping of water availab
GA-ASI Marks Another Aviation First with YFQ-42A CCA Flight Testing27.8.2025 23:30:00 CEST | Press release
SAN DIEGO, CALIFORNIA / ACCESS Newswire / August 27, 2025 / The YFQ-42A Collaborative Combat Aircraft, designed and developed by General Atomics Aeronautical Systems, Inc. (GA-ASI), is now conducting flight testing in coordination with the U.S. Air Force. This historic achievement continues the company's rapid creation of new, jet-powered uncrewed platforms chartered by the U.S. Air Force (USAF) to achieve air dominance while being designed for rapid production, in large quantities, at an affordable price. "What a great moment for the U.S. Air Force and for GA-ASI," said GA-ASI President David R. Alexander. "It's been our collaboration that enabled us to build and fly the YFQ-42A in just over a year. It's an incredible achievement and I salute the Air Force for its vision and I salute our development team for delivering yet another historic first for our company." The YFQ-42A is GA-ASI's newest uncrewed jet, focused on air-to-air semi-autonomous operation and based on the genus-species
Telestream Global Ingest Workflow Powered by Vantage Opens the Front Door to Media Creation27.8.2025 16:55:00 CEST | Press release
Unified ingest strategy spans live, camera card, and file-based workflows with hybrid-cloud scalability and system-aware metadata: See it in action at IBC2025 NEVADA CITY, CA / ACCESS Newswire / August 27, 2025 / Telestream, a global leader in media workflow technologies, will debut its new Global Ingest strategy at IBC2025, introducing a next-generation ingest architecture that seamlessly unifies live capture, camera card ingest, and file-based workflows. Built on the proven Vantage platform, the new workflow capabilities are designed for ultimate flexibility, scalability, and efficiency, supporting on-premises, hybrid, and cloud environments. Central to the strategy is Telestream's practical use of AI. Rather than generating unstructured "metadata dumps," Telestream Global Ingest produces structured, system-aware, and standards-compliant metadata at the point of capture. This enables instant interoperability with a wide range of platforms, such as Avid, Iconik, and Mimir, acceleratin
Formerra Appointed Distributor for Italy's Epaflex TPU Lines in the UK & Ireland27.8.2025 15:00:00 CEST | Press release
Agreement combines advanced TPU portfolio with Formerra's expert compliance know-how and agile service. ROMEOVILLE, ILLINOIS / ACCESS Newswire / August 27, 2025 / Formerra, a leader in performance materials distribution, today announced an agreement with Epaflex S.r.l. that designates Formerra Europe as the preferred distributor of Epaflex's thermoplastic polyurethane (TPU) lines in the United Kingdom and Republic of Ireland. The partnership leverages Epaflex's 30-year legacy of innovation in TPU manufacturing with Formerra's deep expertise in UK/EU REACH compliance, local technical support, and agile logistics. Additionally, the collaboration ensures that process engineers and sourcing managers across cable, wire, industrial, automation, and oil & gas markets gain seamless access to high-performance TPU grades backed by responsive service and regulatory guidance. "We're proud to welcome Epaflex's industry-leading TPU portfolio into our specialist distribution network," said Ronan Kenn
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom